Supported by AstraZeneca, Novartis and Roche
Artificial intelligence has given rise to great expectations for improving cancer diagnosis, prognosis and therapy but has also highlighted some of its inherent outstanding challenges, such as potential implicit biases in training datasets, data heterogeneity and the scarcity of external validation cohorts.
SPCC will carry out a project to develop knowledge and competences on integration of AI in Cancer Care Continuum: from diagnosis to clinical decision-making.
Supported by AstraZeneca
The outbreak of the Coronavirus disease 2019 (COVID-19) pandemic has caused worldwide problems in the care of cancer patients. In particular, the therapy of cancer patients, both outpatient and inpatient, has been substantially impacted by major restrictions due to the isolation and hygiene measures.
The aim of this project is to spread awareness and knowledge among HCPs on what is currently available to protect at-risk patients, prevent more serious damage due to COVID-19 disease and improve patients' quality of life in a COVID-19 risk or infection setting.
Supported by AstraZeneca and Daiichi Sankyo
Interstitial lung disease (ILD) is an issue in many cancers and cancer treatments.
This multi-step project will consist of: 1) an online Task Force; 2) a Scientific Position Statement; 3) five Podcasts; 4) a series of Educational Webinars; 5) a Virtual Event.
Supported by AstraZeneca, Eisai and Pfizer
Telemedicine promises to revolutionize care pathways for cancer patients as modern health systems design and conceptualize new ways to manage the entire Cancer Care Continuum, moving from hospital-centered models of care to patient-centered, proximity-based approaches. The fundamental concept is that information and data move, not patients.
Supported by Bayer and Lilly
The Precision Testing Online Educational Course consisted of a 2-day online course focusing on the outcomes of the 2021 webinar series.
Supported by Bayer, Lilly and Pfizer
The Precision Testing Project, pursuing the goal to increase knowledge and awareness among clinicians and patients, was a platform of mutual learning and exchange. It identified key messages and educational content needed to improve the appropriate use of precision testing.
Supported by Bristol-Myers Squibb
ESO, ECO and All.Can among others have published position papers on the topic of efficiency improvement in cancer care.
Supported by Pfizer
Pfizer partnered with SPCC on an RFP-driven grant-making initiative to provide funding to European healthcare institutions and organizations for improving the quality of breast cancer care in their hospitals, health systems, or cancer care centers.
Supported by Fresenius Kabi and Helsinn
Cachexia and malnutrition, important predictors of anticancer treatment success, should be detected at cancer diagnosis, treated as early as possible to improve the patients’ quality of life.